The University of Newcastle,
Researcher report.
| Researcher: | Conjoint Pr David Henry |
| School: | School of Medicine and Public Health |
| Commenced with Institution: | 21-FEB-1983 |
| Personal URL: |
Funded Projects
Please note, only grants administered through the University of Newcastle Research Office are recorded here. For a more complete picture of the researcher's grant history a Personal URL may be supplied, above.
|
Research Higher Degree Supervision
For a more complete picture of the researcher's supervision history a Personal URL may be supplied at the top of this page.
Current Student Supervision
|
Total Equivalent Full-time Student Units (EFTSU):
|
Student Completions
NB - the completions shown here are only those for the University of Newcastle obtained since 2001.
|
Research Publications
Please note, the publications listed here:
(1) relate to the researcher's position at the University of Newcastle only
(2) are for selected categories of publications, and
(3) relate to publication year 1998, onwards.
For a more complete picture of the researcher's publication history a Personal URL may be supplied at the top of this page.
Journal Article
McGettigan Patricia Geraldine, Han Pearline Yoke, Jones Lisa Jane, Whitaker Diana Elizabeth, Henry David Alexander, ’Selective COX-2 inhibitors, NSAIDs and congestive heart failure: Differences between new and recurrent cases’, British Journal of Clinical Pharmacology, 65 927-934 (2008) [C1]
Pit Sabrina Winona, Byles Julie Ellen, Henry David Alexander, Holt L, Hansen Vibeke, Bowman Deborah Anne, ’A Quality Use of Medicines program for general practitioners and older people: A cluster randomised controlled trial’, Medical Journal of Australia, 187 23-30 (2007) [C1]
Henry David Alexander, McGettigan Patricia Geraldine, ’Cyclooxygenase inhibitors and cardiovascular risk - Reply’, JAMA - Journal of the American Medical Association, 297 587-588 (2007) [C3]
Kelman C W, Pearson S A, Day R O, D'Arcy C, Holman J, Kliewer E V, Henry David Alexander, ’Evaluating medicines: let's use all the evidence’, Medical Journal of Australia, 186 249-252 (2007) [C1]
Pearson S A, Ringland C, Kelman C, Mant A, Lowinger J, Stark H, Nichol G, Day R, Henry David Alexander, ’Patterns of analgesic and anti-inflammatory medicine use by Australian veterans’, Internal Medicine Journal, 37 798-805 (2007) [C1]
Searles Andrew Maxwell, Jefferys S, Doran Evan, Henry David Alexander, ’Reference pricing, generic drugs and proposed changes to the Pharmaceutical Benefits Scheme’, Medical Journal of Australia, 187 236-239 (2007) [C1]
Henry David Alexander, McGettigan Patricia Geraldine, ’Selective COX-2 inhibitors: A promise unfulfilled?’, Gastroenterology, 132 790-794 (2007) [C3]
Salkeld G, Henry David Alexander, Hill Suzanne Rose, Lang Danielle Leigh, Freemantle N, D'Assuncao J, ’What drives health-care spending priorities? An international survey of health-care professionals’, Plos Medicine, 4 256-259 (2007) [C1]
McGettigan Patricia Geraldine, Henry David Alexander, ’Cardiovascular risk and inhibition of cyclooxygenase - A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase’, JAMA - Journal of the American Medical Association, 296 1633-1644 (2006) [C1]
Carless Paul Anthony, Henry David Alexander, Moxey Annette Jane, O'Connell Dianne Leslie, Brown T, Fergusson D A, ’Cell Salvage for Minimising Perioperative Allogeneic Blood Transfusion’, Cochrane Database of Systematic Reviews, 4 112 pages (2006) [C1]
Harris A, Hill Suzanne Rose, Henry David Alexander, ’Cost-effectiveness and resource allocation - Reply’, JAMA - Journal of the American Medical Association, 295 2723-2724 (2006) [C3]
McGettigan Patricia Geraldine, Han Pearline Yoke, Henry David Alexander, ’Cyclooxygenase-2 inhibitors and coronary occlusion - Exploring dose-response relationships’, British Journal of Clinical Pharmacology, 62 358-365 (2006) [C1]
Doran Evan, Kerridge I, McNeill P, Henry David Alexander, ’Empirical uncertainty and moral contest: A qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia’, Social Science & Medicine, 62 1510-1519 (2006) [C1]
McNeill P M, Kerridge I H, Henry David Alexander, Stokes Barrie James, Hill Suzanne Rose, Newby David Andrew, MacDonald G J, Day R O, Maguire Jane Margaret, Henderson Kim Maree, ’Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia’, Internal Medicine Journal, 36 571-578 (2006) [C1]
Doran Evan, Henry David Alexander, ’Pharmaceutical benefits scheme policy: confused and tough on patients (Editorial)’, Internal Medicine Journal, 36 211-213 (2006) [C3]
McNeill P M, Kerridge I, Henry David Alexander, ’Reply’, Internal Medicine Journal, 36 796-797 (2006) [C3]
Carless Paul Anthony, Henry David Alexander, ’Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery’, British Journal of Surgery, 93 810-819 (2006) [C1]
Moynihan Ray, Henry David Alexander, ’The fight against disease mongering: Generating knowledge for action’, Plos Medicine, 3 e191 (2006) [C2]
Day R O, Birkett D J, Miners J, Shenfield G M, Henry David Alexander, Seale J P, ’Access to medicines and high-quality therapeutics: Global responsibilities for clinical pharmacology (Conference report)’, Medical Journal of Australia, 182 322-323 (2005) [C1]
Carless Paul Anthony, Moxey Annette Jane, Stokes Barrie James, Henry David Alexander, ’Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials’, BMC Cardiovascular Disorders, 5 12 pages (2005) [C1]
Faunce Thomas, Doran Evan, Henry David Alexander, Drahos Peter, Searles Andrew, Pekarsky Brita, Neville Warwick, ’Assessing the impact of the Australian-United States free trade agreement on Australian and global medicines policy’, Globalization and Health, 1 10 pages (2005) [C1]
Moxey Annette Jane, O'Connell D L, Treloar C J, Han P Y S, Henry David Alexander, ’Blood transfusion and autologous donation: a survey of post-surgical patients, interest group members and the public’, Transfusion Medicine, 15 19-32 (2005) [C1]
Kerridge I, Maguire Jane Margaret, Newby David Andrew, McNeill P M, Henry David Alexander, Hill Suzanne Rose, Day R, MacDonald G, Stokes Barrie James, Henderson Kim Maree, ’Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations’, Internal Medicine Journal, 35 206-210 (2005) [C1]
Henry David Alexander, Hill Suzanne Rose, Harris A, ’Drug prices and value for money: The Australian Pharmaceutical Benefits Scheme (Commentary)’, Journal of the American Medical Association, 294 2630-2632 (2005) [C1]
McGettigan Patricia Geraldine, Henry David Alexander, ’Medical research and the news media’, New England Journal of Medicine, 352 838-840 (2005) [C1]
Henry David Alexander, Kerridge I H, Hill Suzanne Rose, McNeill P M, Doran Evan, Newby David Andrew, Henderson Kim Maree, Maguire Jane Margaret, Stokes Barrie James, MacDonald G J, Day R O, ’Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience’, Medical Journal of Australia, 182 557-560 (2005) [C1]
Smith David E, Wilson Amanda Jane, Henry David Alexander, ’Monitoring the quality of medical news reporting: Early experience with media doctor’, Medical Journal of Australia, 183 190-193 (2005) [C1]
Doran Evan, Robertson Jane, Henry David Alexander, ’Moral hazard and prescription medicine use in Australia - the patient perspective’, Social Science & Medicine, 60 1437-1443 (2005) [C1]
Carless Paul Anthony, Henry David Alexander, ’Systematic review of autologous transfusion techniques (Reply)’, Transfusion Medicine, 15 256-256 (2005) [C3]
Henry David Alexander, Doran Evan, Kerridge Ian, Hill Suzanne Rose, McNeill P M, Day R, ’Ties that bind - Multiple relationships between clinical researchers and the pharmaceutical industry’, Archives of Internal Medicine, 165 2493-2496 (2005) [C1]
Schwitzer G, Mudur G, Henry David Alexander, Wilson Amanda Jane, Goozner M, Simbra M, Sweet M, Baverstock K A, ’What are the roles and responsibilities of the media in disseminating health information?’, Plos Medicine, 2 576-582 (2005) [C1]
Carless Paul Anthony, Moxey Annette Jane, O'Connell Dianne Leslie, Henry David Alexander, ’Autologous transfusion techniques: systematic review of their efficacy’, Transfusion Medicine, 14 123-144 (2004) [C1]
Carless Paul Anthony, Henry David Alexander, Moxey Annette Jane, O'Connell Dianne Leslie, McClelland B, Henderson Kim Maree, Sly Ketrina, Laupacis A, Fergusson D, ’Desmopressin for minimising perioperative allogenic blood transfusion’, Cochrane Database of Systematic Reviews, 1 - (2004) [C5]
Atkins David, Best Dana, Briss Peter A, Eccles Martin, Falck-Ytter Yngve, Flottorp Signe, Guyatt Gordon H, Harbour Robin T, Haugh Margaret C, Henry David Alexander, Hill Suzanne Rose, Jaeschke Roman, Leng Gillian, Liberati Alessandro, Magrini Nicola, Mason James, Middleton Philippa, Mrukowicz Jacek, O'Connell Dianne, Oxman Andrew D, Phillips Bob, Schunemann Holger J, Edejer Tessa Tan-Torres, Varonen Helena, Vist Gunn E, Williams Jr John W, Zaza Stephanie, ’Grading quality of evidence and strength of recommendations’, BMJ, 328 1-8 (2004) [C1]
Mansfield Peter R, Henry David Alexander, ’Misleading drug promotion- no sign of improvements’, Pharmacoepidemiology and drug safety, 13 797-799 (2004) [C3]
Doran Evan, Robertson Jane, Rolfe Isobel Evelyn, Henry David Alexander, ’Patient co-payments and use of prescription medicines’, Australian and New Zealand Journal of Public Health, 28 62-67 (2004) [C1]
Drahos Peter, Lokuge Buddhima, Faunce Tom, Goddard Martyn, Henry David Alexander, ’Pharmaceuticals, Intellectual Property and Free Trade: The Case of the US-Australia Free Trade Agreement’, Promethus, 22 243-257 (2004) [C1]
Mansfield Peter, Henry David Alexander, Tonkin Anne, ’Single-Enantiomer Drugs. Elegant Science, Disappointing Effects’, Clinical Pharmacokinetics, 43 287-290 (2004) [C1]
Atkins David, Eccles Martin, Flottorp Signe, Guyatt Gordon H, Henry David Alexander, Hill Suzanne Rose, Liberati Alessandro, O'Connell Dianne Leslie, Oxman Andrew D, Phillips Bob, Scunemann Holger, Edejer Tessa Tan-Torres, Vist Gunn E, Williams J, ’Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group’, BMC Health Services Research, 4 1-7 (2004) [C1]
Drahos Peter, Henry David Alexander, ’The free trade agreement between Australia and the United States, Undermines Australian public health and protects US interests in pharmaceuticals’, BMJ, 328 1271-1272 (2004) [C3]
Henry David Alexander, Salkeld Glenn, ’Bridges to Iran’, The Lancet, 361 438 (2003) [C4]
Lelorier Jacques, Vander Stichele Robert H, Avorn Jerry, Beard Keith, Hallas Jesper, Henry David Alexander, ’Bringing epidemology into drug utilisation research’, Pharmacoepidemiology & Drug Safety: an International Journal, 12 153-156 (2003) [C1]
Moxey Annette Jane, O'Connell Dianne Leslie, McGettigan Patricia Geraldine, Henry David Alexander, ’Describing Treatment Effects to Patients’, Journal of General Internal Medicine, 18 948-959 (2003) [C1]
Newby David Andrew, Fryer Jayne Louise, Henry David Alexander, ’Effect of computerised prescribing on use of antibiotics’, Medical Journal of Australia, 178 210-213 (2003) [C1]
Henry David Alexander, McGettigan Patricia Geraldine, ’Epidemiology overview of gastrointestinal and renal toxicity of NSAIDs’, International Journal of Clinical Practice, 135 43-49 (2003) [C1]
Carless Paul Anthony, Henry David Alexander, Anthony Danielle Marie, ’Fibrin sealant use for minimising peri-operative allogeneic blood transfusion’, Cochrane Database of Systematic Reviews, 4 (2003) [C4]
Carless Paul Anthony, Rubens F D, Anthony Danielle Marie, O'Connell Dianne Leslie, Henry David Alexander, ’Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusion’, Cochrane Data Base of Systematic Reviews, 3 (2003) [C4]
Henry David Alexander, Lang Danielle Leigh, ’Published pharmacoeconomic analyses: science or marketing?’, Internal Medicine Journal, 33 404-404 (2003) [C4]
Doran Evan, Henry David Alexander, ’The PBS community awareness campaign: how helpful is blaming patients’, Medical Journal of Australia, 179 544-545 (2003) [C1]
Robertson Jane, Treloar Carla Justine, Sprogis Arn, Henry David Alexander, ’The influence of specialists on prescribing GPs: A qualitative study’, Australian Family Physician, 32 573-545 (2003) [C1]
Lopert Ruth, Lang Danielle Leigh, Hill Suzanne Rose, Henry David Alexander, ’Differential pricing of drugs: a role for cost-effectiveness analysis?’, The Lancet, 359 2105-2107 (2002) [C1]
Newby David Andrew, Henry David Alexander, ’Drug advertising: truths, half-truths and few statistics’, Medical Journal of Australia, 177(6) 285-286 (2002) [C4]
Robertson Jane, Fryer Jayne Louise, O'Connell Dianne Leslie, Smith Anthony Neil, Henry David Alexander, ’Limitations of Health Insurance Commission (HIC) data for deriving prescribing indicators’, Medical Journal of Australia, 176 419-424 (2002) [C1]
Henry David Alexander, Carless Paul Anthony, Moxey Aj, O'Connell Dianne Leslie, Forgie Ma, Wells Ps, Fergusson D, ’Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion’, The Cochrane Library, 2002 Issue 4 On-line (2002) [C4]
Moynihan R, Heath I, Henry David Alexander, ’Selling sickness: The pharmaceutical industry and disease mongering’, British Medical Journal, 324 886-891 (2002) [C1]
Carless Paul Anthony, Anthony Danielle Marie, Henry David Alexander, ’Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion’, British Journal of Surgery, 89 695-703 (2002) [C1]
Lopert Ruth, Henry David Alexander, ’The Pharmaceutical Benefits Scheme: economic evaluation works ... but is not a panacea’, Australian Prescriber, 25(6) 126-127 (2002) [C1]
Henry David Alexander, Lexchin J, ’The Pharmaceutical Industry as a medicines provider’, The Lancet, 360 1590-1595 (2002) [C1]
Carson J, Hill Suzanne Rose, Carless Paul Anthony, Hebert P, Henry David Alexander, ’Transfusion Triggers: a systematic review of the literature’, Transfusion Medicine Reviews, 16(3) 187-199 (2002) [C1]
Hill Suzanne Rose, Carless Paul Anthony, Henry David Alexander, Carson Jl, Hebert Pc, McClelland Dbl, Henderson Km, ’Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion’, The Cochrane Library, 2002 Issue 4 On-line (2002) [C3]
Wells G, Tugwell P, Shea B, Guyatt G, Peterson J, Zytaruk N, Robinson V, Henry David Alexander, O'Connell Dianne Leslie, Cranney A, ’V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women’, Endocrine Reviews, 23(4) 529-539 (2002) [C1]
Henry David Alexander, Birkett D, ’Changes to the Pharmaceutical Benefits Advisory Committee’, Medical Journal of Australia, 174(5) 209-210 (2001) [C4]
Newby David Andrew, Hill Suzanne Rose, Barker B, Drew A, Henry David Alexander, ’Drug information for consumers: should it be disease or medication specific? Results of a community survey’, Australian and New Zealand Journal of Public Health, 25(6) 564-570 (2001) [C1]
Treloar C, Hewitson P, Henderson Kim Maree, Harris G, Henry David Alexander, McGrath K, ’Factors influencing the uptake of technologies to minimize perioperative allogeneic blood transfusion: an interview study of national and institutional stakeholders’, Internal Medicine Journal, 31 230-236 (2001) [C1]
Robertson Jane, Fryer Jayne Louise, O'Connell Dianne Leslie, Smith Anthony Neil, Henry David Alexander, ’Personal Formularies. An index of prescribing quality?’, European Journal of Clinical Pharmacology, 57 333-341 (2001) [C1]
Robertson Jane, Fryer Jayne Louise, O'Connell Dianne Leslie, Sprogis A, Henry David Alexander, ’The impact of specialists on prescribing by general practitioners’, Medical Journal of Australia, 175 407-411 (2001) [C1]
Page J, Henry David Alexander, ’Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly Patients’, Archives of Internal Medicine, 160(6) 777-784 (2000) [C1]
Moynihan M, Bero B, Ross-Degnan R, Henry David Alexander, Lee L, Soumerai H, ’Coverage by the news media of the benefits and risks of medications’, The New England Journal of Medicine, 342(22) 1645-1650 (2000) [C1]
Hill Suzanne Rose, Mitchell A, Henry David Alexander, ’Problems with the Interpretation of Pharmacoeconomic Analyses’, JAMA, 283(16) 2116-2121 (2000) [C1]
McManus M, Henry David Alexander, Birkett B, ’Recent changes in the profile of prescription NSAID use in Australia’, Medical Journal of Australia, 172 188 (2000) [C4]
Henry David Alexander, McGettigan Patricia Geraldine, ’Rofecoxib caused few endoscopic gastroduodenal ulcers than ibuprofen in osteoarthritis ( Laine L et al/Celecoxib was similar to naproxen for rheumatoid arthritis with fewer endoscopic ulcers (Simon LS et al) - Commentary’, Evidence-Based Medicine (EBM), 5 74 (2000) [C4]
Lowe J, Candish P, Henry David Alexander, Wlodarcyk J, Fletcher P, ’Specialist or generalist care? A study of the impact of a selective admitting policy for patients with cardiac failure’, International Journal for Quality in Health Care, 12(4) 339-345 (2000) [C1]
Henry David Alexander, Henderson Kim Maree, Fryer Jayne Louise, Treloar C, McGrath K, Deveridge S, ’Use of interventions to minimise perioperative allogeneic blood transfusion in Australia’, Medical Journal of Australia, 172 365-369 (2000) [C1]
Henry David Alexander, Hill Suzanne Rose, ’Assessing new health technologies: lessons to be learned from drugs’, Medical Journal of Australia, 171 554 - 556 (1999) [C1]
Whitworth J, Lang Danielle Leigh, Henry David Alexander, ’Cost-effectiveness Analysis in the Treatment of Hypertension: A Medical View’, Clinical and Experimental Hypertension, 21(5-6) 999-1008 (1999) [C1]
Nikolajevic-Sarunac J, Henry David Alexander, O'Connell Dianne Leslie, Robertson Jane, ’Effects of information framing on the intentions of family physicians to prescribe long-term hormone replacement therapy’, Journal of General Internal Medicine, 14 591-598 (1999) [C1]
Henry David Alexander, Hill Suzanne Rose, ’Meta-analysis - Its Role in Assessing Drug Safety’, Pharmacoepidemiology and Drug Safety, 8(3) 167-168 (1999) [C2]
Henry David Alexander, Robertson Jane, ’Pharmacists' outreach visits and doctors' prescribing’, Medical Journal of Australia, 170 460-461 (1999) [C2]
Henry David Alexander, Lopert Ruth, ’Pharmacoeconomics and Policy Decisions: The Australian Health Care System’, Clinical Therapeutics, 21(5) 909 - 915 (1999) [C1]
Robertson Jane, Henry David Alexander, Dobbins T, Sprogis A, Terry R, Ireland M, ’Prescribing patterns in general practice’, Australian Family Physician, 28 (11) 1186-1190 (1999) [C1]
O'Connell Dianne Leslie, Henry David Alexander, Tomlins R, ’Randomised controlled trial of effect of feedback on general practitioners' prescribing in Australia’, British Medical Journal, 318 507-511 (1999) [C1]
Ferguson D, Blair A, Henry David Alexander, Hisashige A, Huet C, Koopman-Van Gemert A, Katz E, McClelland B, Sigmund H, Laupacis A, ’Technologies to minimize blood transfusion in cardiac and orthopedic surgery’, International Journal of Technology Assessment in Health Care, 15 (4) 717-728 (1999) [C1]
McGettigan Patricia Geraldine, Sly K, O'Connell Dianne Leslie, Hill Suzanne Rose, Henry David Alexander, ’The Effects of Information Framing on the Practices of Physicians’, Journal of General Internal Medicine, 14 633-642 (1999) [C1]
Henry David Alexander, Robertson Jane, O'Connell Dianne Leslie, Gillespie W, ’A systematic review of the skeletal effects of estrogen therapy in post-menopausal women. I. An assessment of the quality of randomized trials published between 1977 and 1995’, Climacteric, 1 (2) 92 - 111 (1998) [C1]
O'Connell Dianne Leslie, Robertson Jane, Henry David Alexander, Gillespie W, ’A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects’, Climacteric, 1 (2) 112-123 (1998) [C1]
Henry David Alexander, ’Commentary’, ACP Journal Club, July/August 1998 10 (1998) [C4]
Kerridge I, Lowe M, Henry David Alexander, ’Ethics and Evidence-Based Medicine’, British Medical Journal, 316 1151-1153 (1998) [C1]
Lowe J, Candish P, Henry David Alexander, Wiodarcul J, Heller E, Fletcher P, ’Management and outcomes of congestive heart failure: a prospective study of hospitalised patients’, Medical Journal of Australia, 168 115-118 (1998) [C1]
Porteous J, Robertson Jane, Henry David Alexander, ’Pharmaceutical security: a new research agenda?’, The Medical Journal of Australia, 169 (5) 262-263 (1998) [C2]
Chapter in Book
Henry David Alexander, McGettigan Patricia Geraldine, Tonkin Anne, Hennessy Sean, ’Basic principles of clinical pharmacology relevant to pharmacoepidemiology studies’, Pharmacoepidemiology, John wiley & Sons, West Sussex England, 867 (2005) [B1]
O'Connell Dianne Leslie, Glasziou P, Hill Suzanne Rose, Sarunac J, Lowe Julia, Henry David Alexander, ’Results of Clinical Trials and Systematic Reviews: To Whom Do They Apply?’, The Advanced Handbook of Methods in Evidence Based Healthcare, Sage Publications Ltd, London England, 56-72 (2001) [B1]
Hill Suzanne Rose, Henry David Alexander, Stevens A, ’The use of evidence in drug selection: The Australian Pharmaceutical Benefits Scheme’, Informing Judgment: Case Studies of Health Policy and Research in Six Countries, Milbank Memorial Fund, U.S.A., 7-27 (2001) [B2]
McGettigan Patricia Geraldine, Henry David Alexander, Hennessy S, ’Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiology Studies’, Pharmacoepidemiology, John Wiley & Sons, West Sussex. England, 41-62 (2000) [B1]
Hill Suzanne Rose, Henry David Alexander, ’National Medicinal Drug Policies: their Relationship to Pharmacoepidemiology’, Pharmacoepidemiology, John Wiley & Sons Ltd, Great Britain, 433-447 (2000) [B1]
Henry David Alexander, Drew A, Beuzeville S, ’Gastrointestinal Adverse Drug Reactions Attributed to Ibuprofen’, Ibuprofen A critical bibliographic review, T.J. International Ltd., Cornwall UK, 431-458 (1999) [B1]
Review
Carless Paul Anthony, Henry David Alexander, Moxey Annette Jane, O'Connell Dianne Leslie, Fergusson D A, ’Cell salvage for minimising perioperative allogeneic blood transfusion’, Cochrane Database of Systematic Reviews (2004) [D1]
Hill Suzanne Rose, Carless Paul Anthony, Henry David Alexander, Carlson J L, Herbert P C, McClelland D B L, Henderson Kim Maree, ’Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion’, Cochrane Database of Systematic Reviews (2004) [D1]
Henry David Alexander, Moxey Annette Jane, Carless Paul Anthony, O'Connell Dianne Leslie, McClelland B, Henderson Kim Maree, Sly Ketrina, Laupacis A, Fergusson D, ’Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion’, Cochrane Database of Systematic Reviews (2003) [D2]
Aaserud M, Dahlgren A T, Sturm H, Kosters J P, Hill Suzanne Rose, Furberg C D, Grilli R, Henry David Alexander, Oxman A D, Ramsay C, Ross-Degnan D, Soumerai S B, ’Pharmaceutical policies: effects on rational drug use’, Cochrane Database of Systematic Reviews (2003) [D1]
Conference Publication
Moxey Annette Jane, O'Connell Dianne Leslie, Deveridge Sandra Faye, Treloar Carla Justine, Henry David Alexander, ’Involving older patients in decision making: a decision aid describing blood transfusion options for planned surgery’, Abstracts and Proceedings of ERA 2004, Brisbane (2004) [E1]
Carless Paul Anthony, Hill Suzanne Rose, Henry David Alexander, ’How low can we go? Lower thresholds for red cell transfusion’, Destination downunder turning your thinking upside down : proceedings of the 4th International Conference on the Scientific Basis of Health Services, Sydney, Australia (2001) [E3]
Henry David Alexander, Drew A, Beuzeville S, ’Adverse drug reactions in the gastrointestinal system attributed to ibuprofen’, Safety and Efficacy of Non-Prescription (OTC) Analgesics and NSAIDs, South San Francisco Conference Centre (1998) [E1]
McGettigan Patricia Geraldine, Henry David Alexander, Page J, ’Adverse effects of non-steroidal anti-inflammatory drugs on the gastrointestinal tract and kidney: Relationship to cyclooxygenase-2 selectivity’, Clinical significance and potential of selective COX-2 inhibitors, Phuket, Thailand (1998) [E2]
Skills
Key Words
Countries
Languages